The use of the glucocorticoid receptor antagonist mifepristone in Cushing's syndrome

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 19, Issue 4, 2012, Pages 295-299

  Castinetti, Frederic ^a   Brue, Thierry ^a   Conte Devolx, Bernard ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Adrenal carcinoma; Anticortisolic drug; Bilateral adrenal hyperplasia; Cushing's disease; Cushing's syndrome; Ectopic ACTH secretion; Glucocorticoid receptor antagonist

Indexed keywords

ALDOSTERONE ANTAGONIST; ANTIDIABETIC AGENT; DEXAMETHASONE; ESTROGEN RECEPTOR; HYDROCORTISONE; KETOCONAZOLE; METYRAPONE; MIFEPRISTONE; MINERALOCORTICOID RECEPTOR; MITOTANE; POTASSIUM;

ADRENAL CORTEX CARCINOMA; ADRENAL CORTEX INSUFFICIENCY; ADRENAL INSUFFICIENCY; BIOLOGICAL MONITORING; BLOOD PRESSURE; CUSHING SYNDROME; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG WITHDRAWAL; ENDOMETRIUM HYPERPLASIA; GYNECOMASTIA; HUMAN; HYPERCORTISOLISM; HYPOGLYCEMIA; HYPOKALEMIA; IMPOTENCE; LOW DRUG DOSE; NAUSEA; RASH; RETROSPECTIVE STUDY; REVIEW; SIDE EFFECT; VAGINA BLEEDING; WATER RETENTION;

ADOLESCENT; ADULT; BLOOD PRESSURE; CHILD, PRESCHOOL; CUSHING SYNDROME; FEMALE; HORMONE ANTAGONISTS; HUMANS; HYPOKALEMIA; MALE; MIDDLE AGED; MIFEPRISTONE; RECEPTORS, GLUCOCORTICOID; YOUNG ADULT;

EID: 84864613071     PISSN: 1752296X     EISSN: 17522978     Source Type: Journal    
DOI: 10.1097/MED.0b013e32835430bf     Document Type: Review

References (20)

1. Newell-Price J, Bertagna X, Grossman AB, Nieman LK. Cushing's syndrome. Lancet 2006; 367:1605-1617.
2. Biller BM, Grossman AB, Stewart PM, et al. Treatment of adrenocorticotropindependent cushing's syndrome: a consensus statement. J Clin Endocrinol Metab 2008; 93:2454-2462.
3. Castinetti F, Morange I, Jaquet P, et al. Ketoconazole revisited: a preoperative or postoperative treatment in cushing's disease. Eur J Endocrinol 2008; 158:91-99.
4. Duarte PA, Chow CC, Simmons F, Ruskin J. Fatal hepatitis associated with ketoconazole therapy. Arch Internal Med 1984; 144:1069-1070.
5. Terzolo M, Angeli A, Fassnacht M, et al. Adjuvant mitotane treatment for adrenocortical carcinoma. N Engl J Med 2007; 356:2372-2380.
6. Hahner S, Fassnacht M. Mitotane for adrenocortical carcinoma treatment. Curr Opin Investig Drugs 2005; 6:386-394.
7. Johanssen S, Allolio B. Mifepristone (ru 486) in cushing's syndrome. Eur J Endocrinol 2007; 157:561-569.
8. Bertagna X, Bertagna C, Luton JP, et al. The new steroid analog ru 486 inhibits glucocorticoid action in man. J Clin Endocrinol Metab 1984; 59:25-28.
9. McMaster A, Ray DW. Drug insight: selective agonists and antagonists of the glucocorticoid receptor. Nature Clin Pract 2008; 4:91-101.
10. Miller JW, Crapo L. The medical treatment of Cushing's syndrome. Endocrine Rev 1993; 14:443-458.
11. Beaufrere B, de Parscau L, Chatelain P, et al. Ru 486 administration in a child with Cushing's syndrome. Lancet 1987; 2:217.
12. Bilgin YM, van der Wiel HE, Fischer HR, De Herder WW. Treatment of severe psychosis due to ectopic Cushing's syndrome. J Endocrinol Investig 2007; 30:776-779.
13. Cassier PA, Abou-Amara-Olivieri S, Artru P, et al. Mifepristone for ectopic acth secretion in metastatic endocrine carcinomas: report of two cases. Eur J Endocrinol 2008; 158:935-938.
14. Castinetti F, Fassnacht M, Johanssen S, et al. Merits and pitfalls of mifepristone in cushing's syndrome. Eur J Endocrinol 2009; 160:1003-1010.
15. Chu JW, Matthias DF, Belanoff J, et al. Successful long-term treatment of refractory Cushing's disease with high-dose mifepristone (ru 486). J Clin Endocrinol Metab 2001; 86:3568-3573.
16. Contreras P. Adrenal cancer: tumor regression with ketoconazole or mifepristone (ru 486). In vivo and in vitro evidence supporting tumoral hormone dependency. Proceedings of the 69th Annual-Endocrine Society Meeting, Indianapolis; 1987. pp. 23.
17. Donckier JE, Michel LA, Berbinschi A, et al. Late recurrence of operated adrenocortical carcinoma: atrial natriuretic factor before and after treatment with mitotane. Surgery 1989; 105:690-692.
18. Newfield RS, Spitz IM, Isacson C, New MI. Long-term mifepristone (ru486) therapy resulting in massive benign endometrial hyperplasia. Clin Endocrinol 2001; 54:399-404.
19. Nieman LK, Chrousos GP, Kellner C, et al. Successful treatment of Cushing's syndrome with the glucocorticoid antagonist ru 486. J Clin Endocrinol Metab 1985; 61:536-540.
20. van der Lely AJ, Foeken K, van der Mast RC, Lamberts SW. Rapid reversal of acute psychosis in the cushing syndrome with the cortisol-receptor antagonist mifepristone (ru 486). Ann Internal Med 1991; 114:143-144.